GENOMIC HEALTH, INC.
Patent Owner
Stats
- 40 US PATENTS IN FORCE
- 5 US APPLICATIONS PENDING
- Feb 27, 2018 most recent publication
Details
- 40 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 1,942 Total Citation Count
- Oct 18, 2001 Earliest Filing
- 31 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0121,780 METHOD TO USE GENE EXPRESSION TO DETERMINE LIKELIHOOD OF CLINICAL OUTCOME OF RENAL CANCERDec 05, 16May 04, 17[G06N, C12Q, G06F]
2016/0259,881 METHODS OF INCORPORATION OF TRANSCRIPT CHROMOSOMAL LOCUS INFORMATION FOR IDENTIFICATION OF BIOMARKERS OF DISEASE RECURRENCE RISKOct 28, 14Sep 08, 16[C12Q, G06F]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9551034 Method to use gene expression to determine likelihood of clinical outcome of renal cancerJan 07, 11Jan 24, 17[C12Q, G01N]
8868352 Predicting response to chemotherapy using gene expression markersMar 16, 11Oct 21, 14[C12Q, G06F]
8765383 Methods of predicting cancer risk using gene expression in premalignant tissueApr 06, 10Jul 01, 14[C12Q]
8725426 Gene expression profile algorithm and test for determining prognosis of prostate cancerJan 28, 13May 13, 14[C12Q, G06F]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2014/0303,002 Gene Expression Profile Algorithm and Test for Determining Prognosis of Prostate CancerAbandonedMar 21, 14Oct 09, 14[C12Q, G06F]
2014/0206,545 GENE EXPRESSION MARKERS FOR PREDICTION OF PATIENT RESPONSE TO CHEMOTHERAPYAbandonedDec 18, 13Jul 24, 14[C12Q]
2013/0274,127 GENE EXPRESSION MARKERS FOR PREDICTION OF RESPONSE TO PHOSPHOINOSITIDE 3-KINASE INHIBITORSAbandonedMar 14, 13Oct 17, 13[C12Q]
2013/0102,492 GENE EXPRESSION MARKERS FOR COLORECTAL CANCER PROGNOSISAbandonedDec 28, 12Apr 25, 13[C12Q]
2012/0270,228 PREDICTORS OF PATIENT RESPONSE TO TREATMENT WITH EGF RECEPTOR INHIBITORSAbandonedJul 05, 12Oct 25, 12[C12Q]
2012/0178,644 GENE EXPRESSION PROFILING OF EGFR POSITIVE CANCERAbandonedJan 10, 12Jul 12, 12[C12Q, C40B]
8148076 Gene expression profiling of EGFR positive cancerExpiredJun 01, 11Apr 03, 12[C07H, C12Q, C12M]
2012/0028,264 METHOD FOR USING GENE EXPRESSION TO DETERMINE PROGNOSIS OF PROSTATE CANCERAbandonedJul 25, 11Feb 02, 12[C12Q]
2012/0009,581 Gene Expression Profiling for Predicting the Survivability of Prostate Cancer SubjectsAbandonedJul 08, 09Jan 12, 12[C12Q, G01N]
2011/0287,958 Method for Using Gene Expression to Determine Colorectal Tumor StageAbandonedMay 19, 11Nov 24, 11[C12Q, G01N, C40B]
8008003 Gene expression profiling of EGFR positive cancerExpiredNov 14, 03Aug 30, 11[C07H, C12Q, C12M]
2010/0267,032 Prediction of Likelihood of Cancer RecurrenceAbandonedFeb 17, 10Oct 21, 10[C12Q, C40B]
2010/0233,691 Gene Expression Profiling for Identification, Monitoring and Treatment of Prostate CancerAbandonedNov 06, 07Sep 16, 10[C12Q]
2010/0209,920 Gene Expression Profiling in Biopsied Tumor TissuesAbandonedNov 10, 09Aug 19, 10[C12Q]
2010/0184,041 Molecular Indicators of Breast Cancer Prognosis and Prediction of Treatment ResponseAbandonedOct 09, 09Jul 22, 10[C12Q]
2010/0151,463 Method for Determining the Likelihood of Response to HER2 InhibitorsAbandonedSep 04, 09Jun 17, 10[C12Q]
2009/0311,702 TESTS TO PREDICT RESPONSIVENESS OF CANCER PATIENTS TO CHEMOTHERAPY TREATMENT OPTIONSAbandonedMay 12, 09Dec 17, 09[C12Q, G01N]
2009/0258,795 Gene expression markers for prediction of patient response to chemotherapyAbandonedMar 14, 08Oct 15, 09[C12Q, C40B]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
